Abstract:within 1 day after spinal cord injury (SCI) or ischemic stroke in mice 8,11 . Additionally, ATF3 protein levels in mouse blood significantly increased 1 day after SCI as well as after ischemic stroke 11 . Most importantly, ATF3 protein levels in human serum were elevated in patients within 24 hours after SCI or ischemic stroke 11 . These results demonstrate the feasibility of using ATF3 level in patients' serum as a potential biomarker for CNS trauma 11 .One of the primary contexts in which ATF3 has been studied is neuronal injury 12 . Following axonal damage, ATF3 expression is markedly increased in affected neurons, which is believed to contribute to the cellular response aimed at repair and regeneration 13 . For instance, in models of peripheral nerve injury, ATF3 has been shown to promote neurite outgrowth and to enhance the intrinsic growth capacity of neurons (reviewed in 14 ).Comparing RNA expression data across species that exhibit different abilities to regenerate their nervous system following traumatic nerve injury reveals that ATF3 is consistently induced in neurons within the first few days after injury. Thus, ATF3 can definitely be considered as an evolutionary conserved regulator of neuronal regeneration 14 .ATF3 also modulates the response of the CNS to inflammation and psychological stress. In conditions of neuroinflammation, such as those observed in multiple sclerosis and other neurodegenerative diseases, ATF3 expression is upregulated in glial cells (reviewed in 4 ), including astrocytes and microglia. This upregulation is associated with the modulation of inflammatory responses 15 , which can be either protective or detrimental depending upon the context and duration of the stressor. It has been mentioned that targeting microglial ATF3 upregulation to mitigate inflammation would be an interesting and necessary therapeutic avenue across a range of CNS disease 16 . Regarding cell death, ATF3 has been reported to be either pro-apoptotic or anti-apoptotic. For instance, the neuroinflammatory response during Alzheimer disease (AD) is triggered by microglia secreting pro-inflammatory cytokines, including CCL4, which attracts astrocytes to encapsulate plaques. Noteworthy, CCL4 is undetectable in normal brain, however, it is significantly present in AD brain at increased concentrations and is positively correlated with amyloid deposition. As ATF3 was found to bind to the promoter region of the CCL4 gene and to positively regulate its transcription, it was concluded that AD progression is controlled also by ATF3 which regulates the associated neuroinflammation pathways (reviewed in 17 ). In another study of a mouse model of Parkinson's diseases, ATF3-knockdown decreased CHOP (C/EBP-homologous protein) and cleaved caspase-3 levels (apoptotic markers), suggesting that ATF3 plays a role in apoptosis induction 18 . Additionally, in response to lipotoxic brain microvascular damage, ATF3 was found to mainly govern triglyceride-rich lipoprotein-induced inflammation and TNF signaling in the cerebrovascular system and increase endothelial cell apoptosis 19 .However, in ischemic stroke, ATF3 overexpression attenuated neuronal caspase-dependent apoptosis, microglial activation, and pro-inflammatory cytokine production to alleviate brain injury. ATF3 was also shown to reduce microglia activation and, by doing so, to prevent apoptosis. In addition, ATF3 was shown to prevent neuronal apoptosis by promoting the expression of the anti-apoptotic neuronal survival factor HSP27 and activation of Akt (reviewed in 20 ).Recent studies have explored the role of ATF3 in psychological stress response of the CNS. Chronic stress is known to induce changes in brain function and structure, contributing to mental health disorders like depression and anxiety 21,22 . ATF3 appears to be involved in the cellular mechanisms underlying these changes, influencing neuroplasticity and stress resilience.The multifaceted roles of ATF3 in the CNS suggest that it could become a valuable target for therapeutic interventions aimed at mitigating the effects of CNS stress. For example, enhancing ATF3 expression in neurons might promote recovery after traumatic brain injury or stroke (reviewed in 20 ). Additionally, modulating ATF3 activity in glial cells could help manage chronic neuroinflammation seen in diseases like Alzheimer's 17 and Parkinson's 23 .However, the dual nature of ATF3's actions-promoting repair in some contexts 24 while potentially exacerbating damage in others 17 -necessitates a nuanced approach to therapeutic development. Understanding the precise conditions under which ATF3 exerts its beneficial versus detrimental effects will be crucial for harnessing its potential in clinical settings.ATF3 is a pivotal transcription factor in the CNS response to all forms of stress, playing significant roles in neuronal injury repair, neuroinflammation, recovery from metabolic stress, a -Abstract Truncated-

The Dual Roles of Activating Transcription Factor 3 (ATF3) in Inflammation, Apoptosis, Ferroptosis, and Pathogen Infection Responses

ATF3 Prevents Stress-Induced Hematopoietic Stem Cell Exhaustion

Histone Deacetylase 3 Facilitates TNFα-mediated NF-κB Activation Through Suppressing CTSB Induced RIP1 Degradation and is Required for Host Defense Against Bacterial Infection

ATF4 in cellular stress, ferroptosis, and cancer

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.

ATF3 Positively Regulates Antibacterial Immunity by Modulating Macrophage Killing and Migration Functions

Activating Transcription Factor 3 Regulates Survivability and Migration of Vascular Smooth Muscle Cells

Editorial: ATF3: a crucial stress-responsive gene of glia and neurons in CNS

ATF3 controls proliferation of osteoclast precursor and bone remodeling

ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, And Fibrosis Induced By Pressure Overload

ATF3 as a response factor to regulate Cd-induced reproductive damage by activating the NRF2/HO-1 ferroptosis pathway

Activating transcription factor 3 involved in Pseudomonas aeruginosa PAO1-induced macrophage senescence

Role of ATF3 triggering M2 macrophage polarization to protect against the inflammatory injury of sepsis through ILF3/NEAT1 axis

Involvement of ATF3 in the negative regulation of iNOS expression and NO production in activated macrophages

ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury

An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR

The Roles of ATF3, an Adaptive-Response Gene, in High-Fat-Diet-Induced Diabetes and Pancreatic Β-Cell Dysfunction